BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 38179744)

  • 1. Bioinformatic Analysis and Computer-Aided Study to Investigate the Potential Application of a Bioflavonoid Compound Bilobetin in Liver Cancer Treatment.
    Zhang C; Sui Y; Liu S; Yang M
    Front Biosci (Landmark Ed); 2023 Dec; 28(12):360. PubMed ID: 38179744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Drug Targets and Agents Associated with Hepatocellular Carcinoma through Integrated Bioinformatics Analysis.
    Hossen MA; Reza MS; Harun-Or-Roshid M; Islam MA; Siddika MA; Mollah MNH
    Curr Cancer Drug Targets; 2023; 23(7):547-563. PubMed ID: 36786134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification.
    Lu S; Meng Z; Tan Y; Wu C; Huang Z; Huang J; Fu C; Stalin A; Guo S; Liu X; You L; Li X; Zhang J; Zhou W; Zhang X; Wang M; Wu J
    BMC Complement Med Ther; 2022 Mar; 22(1):54. PubMed ID: 35236335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Hepatocellular Carcinoma.
    Su Q; Li W; Zhang X; Wu R; Zheng K; Zhou T; Dong Y; He Y; Wang D; Ran J
    Curr Pharm Biotechnol; 2023; 24(8):1035-1058. PubMed ID: 35762549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Based on network pharmacology and experiments to explore the underlying mechanism of Mahonia bealei (Fortune) Carrière for treating alcoholic hepatocellular carcinoma.
    Zhang N; Zhu Y; Zhang X; Yang K; Yang X; An M; Tian C; Li J
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116919. PubMed ID: 37453621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatic Evidence Reveals that Cell Cycle Correlated Genes Drive the Communication between Tumor Cells and the Tumor Microenvironment and Impact the Outcomes of Hepatocellular Carcinoma.
    Chen D; Feng Z; Zhou M; Ren Z; Zhang F; Li Y
    Biomed Res Int; 2021; 2021():4092635. PubMed ID: 34746301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Immune-Related Markers in Hepatocellular Carcinoma Based on Gene Co-expression Network.
    Li G; Tian Y; Gao Z; Ma X; Ren C
    Biochem Genet; 2022 Dec; 60(6):2552-2569. PubMed ID: 35633444
    [TBL] [